Literature DB >> 1418979

A PCR-based method for manipulation of the vaccinia virus genome that eliminates the need for cloning.

P C Turner1, R W Moyer.   

Abstract

A general method is described for altering specific genes of vaccinia virus (VV). We demonstrate and evaluate the procedure by gene inactivation, using a dominant selectable marker in conjunction with recombinant polymerase chain reaction (PCR). Primers based on the sequence of the target gene enable amplification of flanking arms and their subsequent attachment to the gpt cassette that confers resistance to mycophenolic acid. Linear PCR constructs are transfected into cells infected with wild-type vaccinia virus. Mutant viruses with gpt inserted into the target gene by homologous recombination are then selected by growth in the presence of MPA. This technique was applied to the vaccinia virus thymidine kinase gene and compared to the traditional method of constructing gpt-containing plasmids by cloning. The PCR scheme was found to be highly efficient and could theoretically be used to insert any foreign DNA element into any nonessential target gene for which partial or complete sequence information is available. The procedure can potentially be used for a wide variety of genetic modifications, including the insertion of foreign genes, with poxviruses and other DNA viruses. Genomes of microorganisms, such as bacteria and yeast that can be transformed with linear DNA, are also candidates for manipulation by this methodology.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1418979

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  7 in total

1.  Recombinant vaccinia viruses. Design, generation, and isolation.

Authors:  C C Broder; P L Earl
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

2.  Genetic analysis of the Mycobacterium smegmatis rpsL promoter.

Authors:  T J Kenney; G Churchward
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

3.  The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.

Authors:  R L Roper; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Vaccinia virus protein A3 is required for the production of normal immature virions and for the encapsidation of the nucleocapsid protein L4.

Authors:  Desyree Murta Jesus; Nissin Moussatche; Baron B D McFadden; Casey Paulasue Nielsen; Susan M D'Costa; Richard C Condit
Journal:  Virology       Date:  2015-03-09       Impact factor: 3.616

5.  Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion.

Authors:  P C Turner; R W Moyer
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

6.  Sheeppox virus kelch-like gene SPPV-019 affects virus virulence.

Authors:  C A Balinsky; G Delhon; C L Afonso; G R Risatti; M V Borca; R A French; E R Tulman; S J Geary; D L Rock
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

7.  Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidine.

Authors:  Mark N Prichard; Earl R Kern; Debra C Quenelle; Kathy A Keith; Richard W Moyer; Peter C Turner
Journal:  Virol J       Date:  2008-03-05       Impact factor: 5.913

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.